Aldesleukin Terminated Phase 1 Trials for Recurrent Neuroblastoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00054405Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma